USFDA8 Feb 2025, 06:00 pm
HIKAL LTD. Completes USFDA Inspection with Six Observations
AI Summary
HIKAL LTD. has announced the completion of a US Food and Drug Administration (USFDA) inspection at its Jigani unit in Bengaluru, Karnataka. The inspection, which took place from 3rd February 2025 to 7th February 2025, resulted in six observations. The company plans to address these observations and submit its response to the USFDA within the specified timeframe.
Key Highlights
- HIKAL LTD. has completed a USFDA inspection at its Jigani unit in Bengaluru, Karnataka
- The inspection took place from 3rd February 2025 to 7th February 2025
- Six observations were made during the inspection
- The company plans to address these observations and submit its response to the USFDA
- The response will be submitted within the stipulated timeframe